WallStreetZenWallStreetZen

NASDAQ: TMCI
Treace Medical Concepts Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

TMCI past revenue growth

How has TMCI's revenue growth performed historically?
Company
31.92%
Industry
9.25%
Market
17.15%
TMCI's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
TMCI's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
TMCI's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

TMCI earnings and revenue history

Current Revenue
$187.1M
Current Earnings
-$49.5M
Current Profit Margin
-26.5%

TMCI Return on Equity

Current Company
-34%
Current Industry
10.5%
Current Market
188%
TMCI's Return on Equity (-34%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when TMCI announces earnings.

TMCI Return on Assets

Current Company
-20%
Current Industry
5.3%
TMCI is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

TMCI Return on Capital Employed

Current Company
-21.44%
Current Industry
8.3%
TMCI's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

TMCI vs Medical Device Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
TMCI$187.12M-$36.55M-$49.53M+47.61%N/A
SILK$177.13M-$45.08M-$55.74M+38.66%N/A
VREX$877.80M$101.70M$44.60M+2.31%+17.29%
KIDS$148.73M-$4.13M-$20.97M+20.91%N/A
SIBN$138.89M-$34.45M-$43.34M+20.19%N/A
View Top Medical Device Stocks

TMCI earnings dates

Next earnings date
May 7, 2024

Treace Medical Concepts Earnings & Revenue FAQ

What were TMCI's earnings last quarter?

On Invalid Date, Treace Medical Concepts (NASDAQ: TMCI) reported Q4 2023 earnings per share (EPS) of -$0.10, up 42.86% year over year. Total Treace Medical Concepts earnings for the quarter were -$6.28 million. In the same quarter last year, Treace Medical Concepts's earnings per share (EPS) was -$0.07.

If you're new to stock investing, here's how to buy Treace Medical Concepts stock.

What was TMCI's earnings growth in the past year?

As of Q2 2024, Treace Medical Concepts's earnings has grown year over year. Treace Medical Concepts's earnings in the past year totalled -$49.53 million.

What is TMCI's earnings date?

Treace Medical Concepts's earnings date is Invalid Date. Add TMCI to your watchlist to be reminded of TMCI's next earnings announcement.

What was TMCI's revenue last quarter?

On Invalid Date, Treace Medical Concepts (NASDAQ: TMCI) reported Q4 2023 revenue of $62.21 million up 25% year over year. In the same quarter last year, Treace Medical Concepts's revenue was $49.77 million.

What was TMCI's revenue growth in the past year?

As of Q2 2024, Treace Medical Concepts's revenue has grown 31.92% year over year. This is 22.67 percentage points higher than the US Medical Devices industry revenue growth rate of 9.25%. Treace Medical Concepts's revenue in the past year totalled $187.12 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.